1. Eligibility criteria and enrollment of a diverse racial and ethnic population in multiple myeloma clinical trials;Kanapuru;Blood,2023
2. Enrolment of racial minorities across 15 years of multiple myeloma randomised trials; calling on researchers to become agents of change;Mohyuddin;Lancet Haematol,2020
3. US Department of Health and Human Services
. Diversity plans to improve enrollment of participants from underrepresented racial and ethnic populations in clinical trials guidance for industry. Draft guidance. April 2022. Accessed 10 March 2023. https://www.fda.gov/media/157635/download.
4. The magic of randomization versus the myth of real-world evidence;Collins;N Engl J Med,2020
5. Howlader
N
, NooneA, KrapchoM, . SEER Cancer Statistics Review, 1975-2016. National Cancer Institute, April 2019 (based on November 2018 SEER data submission). Accessed 10 March 2023. https://seer.cancer.gov/csr/1975_2016/.